Literature DB >> 19778674

Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism.

Stavros Stavrakis1, Xichun Yu, Eugene Patterson, Shijun Huang, Sean R Hamlett, Laura Chalmers, Reji Pappy, Madeleine W Cunningham, Syed A Morshed, Terry F Davies, Ralph Lazzara, David C Kem.   

Abstract

OBJECTIVES: We studied activating autoantibodies to beta-1 adrenergic receptors (AAbeta1AR) and activating autoantibodies to M2 muscarinic receptors (AAM2R) in the genesis of atrial fibrillation (AF) in Graves' hyperthyroidism.
BACKGROUND: Atrial fibrillation frequently complicates hyperthyroidism. Both AAbeta1AR and AAM2R have been described in some patients with dilated cardiomyopathy and AF. We hypothesized that their copresence would facilitate AF in autoimmune Graves' hyperthyroidism.
METHODS: Immunoglobulin G purified from 38 patients with Graves' hyperthyroidism with AF (n=17) or sinus rhythm (n=21) and 10 healthy control subjects was tested for its effects on isolated canine Purkinje fiber contractility with and without atropine and nadolol. Immunoglobulin G electrophysiologic effects were studied using intracellular recordings from isolated canine pulmonary veins. Potential cross-reactivity of AAbeta1AR and AAM2R with stimulating thyrotropin receptor (TSHR) antibodies was evaluated before and after adsorption to Chinese hamster ovary cells expressing human TSHRs using flow cytometry and enzyme-linked immunosorbent assays.
RESULTS: The frequency of AAbeta1AR and/or AAM2R differed significantly between patients with AF and sinus rhythm (AAbeta1AR=94% vs. 38%, p<0.001; AAM2R=88% vs. 19%, p<0.001; and AAbeta1AR+AAM2R=82% vs. 10%, p<0.001). The copresence of AAbeta1AR and AAM2R was the strongest predictor of AF (odds ratio: 33.61, 95% confidence interval: 1.17 to 964.11, p=0.04). Immunoglobulin G from autoantibody-positive patients induced hyperpolarization, decreased action potential duration, enhanced early afterdepolarization formation, and facilitated triggered firing in pulmonary veins by local autonomic nerve stimulation. Immunoadsorption studies showed that AAbeta1AR and AAM2R were immunologically distinct from TSHR antibodies.
CONCLUSIONS: When present in patients with Graves' hyperthyroidism, AAbeta1AR and AAM2R facilitate development of AF.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19778674      PMCID: PMC2801559          DOI: 10.1016/j.jacc.2009.07.015

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  24 in total

Review 1.  Graves' disease.

Authors:  A P Weetman
Journal:  N Engl J Med       Date:  2000-10-26       Impact factor: 91.245

2.  A monoclonal thyroid-stimulating antibody.

Authors:  Takao Ando; Rauf Latif; Alla Pritsker; Thomas Moran; Yuji Nagayama; Terry F Davies
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

3.  Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes.

Authors:  T Christ; E Wettwer; D Dobrev; E Adolph; M Knaut; G Wallukat; U Ravens
Journal:  J Mol Cell Cardiol       Date:  2001-08       Impact factor: 5.000

4.  Autoimmune hypertensive syndrome.

Authors:  David C Kem; Xichun Yu; Eugene Patterson; Shijun Huang; Stavros Stavrakis; Bela Szabo; Leann Olansky; Jon McCauley; Madeleine W Cunningham
Journal:  Hypertension       Date:  2007-10-08       Impact factor: 10.190

5.  Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes.

Authors:  Yao-Chang Chen; Shih-Ann Chen; Yi-Jen Chen; Mau-Song Chang; Paul Chan; Cheng-I Lin
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

6.  Human chagasic IgGs bind to cardiac muscarinic receptors and impair L-type Ca2+ currents.

Authors:  Ciria Carolina Quintero Hernández; Luciane Claudia Barcellos; Luis Eduardo Díaz Giménez; Rafael Armando Bonfante Cabarcas; Simone Garcia; Roberto Coury Pedrosa; Jose Hamilton Matheus Nascimento; Eleonora Kurtenbach; Masako Oya Masuda; Antonio Carlos Campos de Carvalho
Journal:  Cardiovasc Res       Date:  2003-04-01       Impact factor: 10.787

7.  Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction.

Authors:  P A Chiale; I Ferrari; E Mahler; M A Vallazza; M V Elizari; M B Rosenbaum; M J Levin
Journal:  Circulation       Date:  2001-04-03       Impact factor: 29.690

8.  Sera from patients with idiopathic dilated cardiomyopathy decrease ICa in cardiomyocytes isolated from rabbits.

Authors:  Cristiane Del Corsso; Antônio Carlos Campos de Carvalho; Helena Furtado Martino; Wamberto Antonio Varanda
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-07-15       Impact factor: 4.733

9.  Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy.

Authors:  Akiyasu Baba; Tsutomu Yoshikawa; Yukiko Fukuda; Takashi Sugiyama; Megumi Shimada; Makoto Akaishi; Kanji Tsuchimoto; Satoshi Ogawa; Michael Fu
Journal:  Eur Heart J       Date:  2004-07       Impact factor: 29.983

10.  Autoantibodies against the myocardial beta1-adrenergic and M2-muscarinic receptors in patients with congestive heart failure.

Authors:  Lin Zhang; Dayi Hu; Jing Li; Yafeng Wu; Xiulan Liu; Xinchun Yang
Journal:  Chin Med J (Engl)       Date:  2002-08       Impact factor: 2.628

View more
  36 in total

1.  Atrial tachyarrhythmias induced by the combined effects of β1/2-adrenergic autoantibodies and thyroid hormone in the rabbit.

Authors:  Hongliang Li; Benjamin J Scherlag; David C Kem; Alexandria Benbrook; Ling Zhang; Bing Huang; Madeleine W Cunningham; Ralph Lazzara; Xichun Yu
Journal:  J Cardiovasc Transl Res       Date:  2014-06-06       Impact factor: 4.132

Review 2.  The diagnostic and clinical significance of anti-muscarinic receptor autoantibodies.

Authors:  Udi Nussinovitch; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

3.  Agonistic autoantibodies as vasodilators in orthostatic hypotension: a new mechanism.

Authors:  Hongliang Li; David C Kem; Sean Reim; Muneer Khan; Megan Vanderlinde-Wood; Caitlin Zillner; Daniel Collier; Campbell Liles; Michael A Hill; Madeleine W Cunningham; Christopher E Aston; Xichun Yu
Journal:  Hypertension       Date:  2012-01-03       Impact factor: 10.190

Review 4.  Autoantibodies and cardiac arrhythmias.

Authors:  Hon-Chi Lee; Kristin T L Huang; Xiao-Li Wang; Win-Kuang Shen
Journal:  Heart Rhythm       Date:  2011-07-06       Impact factor: 6.343

5.  Autoantibody activation of beta-adrenergic and muscarinic receptors contributes to an "autoimmune" orthostatic hypotension.

Authors:  Xichun Yu; Stavros Stavrakis; Michael A Hill; Shijun Huang; Sean Reim; Hongliang Li; Muneer Khan; Sean Hamlett; Madeleine W Cunningham; David C Kem
Journal:  J Am Soc Hypertens       Date:  2011-11-30

6.  ADRB1 variants in atrial fibrillation: small steps and giant leaps toward personalized therapy in cardiovascular disease.

Authors:  Sharon Cresci
Journal:  J Am Coll Cardiol       Date:  2012-01-03       Impact factor: 24.094

7.  Autoantibodies of β-adrenergic and M2 cholinergic receptors: atrial fibrillation in hyperthyroidism.

Authors:  Guanghong Jia; James R Sowers
Journal:  Endocrine       Date:  2015-02-21       Impact factor: 3.633

8.  Implications of a vasodilatory human monoclonal autoantibody in postural hypotension.

Authors:  Hongliang Li; Jonathan Zuccolo; David C Kem; Caitlin Zillner; Jiyeon Lee; Kenneth Smith; Judith A James; Madeleine W Cunningham; Xichun Yu
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

9.  Targeting individual GPCRs with redesigned nonvisual arrestins.

Authors:  Luis E Gimenez; Sergey A Vishnivetskiy; Vsevolod V Gurevich
Journal:  Handb Exp Pharmacol       Date:  2014

10.  Autoimmune myocarditis, valvulitis, and cardiomyopathy.

Authors:  Jennifer M Myers; DeLisa Fairweather; Sally A Huber; Madeleine W Cunningham
Journal:  Curr Protoc Immunol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.